Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Americans Go Abroad, Online for New Diet Pill

Hung up in FDA approval process, pill's already scoring big

By Dustin Lushing,  Newser Staff

Posted Jun 11, 2007 8:21 PM CDT
Email

(Newser) – The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression, Acomplia could be worth billions to manufacturer Sanofi-Aventis.

Acomplia will be sold as Zimulti in the US, where one-third of the population is obese. The drug stifles hunger by blocking brain receptors and interacts directly with fat cells. The FDA was originally expected to rule on the drug last year, Bloomberg reports; safety questions have forced three postponements, and a decision is now expected next month.

'
'   (Getty Images)
'
'
'
'   (Getty Images)
« Prev« Prev | Next »Next » Slideshow
To report an error on this story, notify our editors.
A snapshot of the day's best news stories.
 
COMMENTS
Be the first to comment on this story.

More on the increased incidence of suicidal thoughts or actions
Reuters

 
medicine • suicide • FDA • depression • obesity epidemic • Sanofi Aventis • Acomplia • weight loss • diet pills • cholesterol

More Newser Stories

FDA Advisory Panel Rejects Weight-Loss Drug

LASIK Patients Urge Better Oversight

FDA Mandates Suicide Risk Assessment in Drug Trials

Antidepressant Warning Preceded Youth Suicide Surge
NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   Betty Confidential   |   BuzzFeed   |   Cracked   |   Fark   |   Timelines   |   The Frisky   |   Geek Sugar   |   NewsOne